Germany’s vaccine regulator reports 31 cases of blood disorder after AstraZeneca shot
The Paul Ehrlich Institute (PEI) said it has now registered 31 cases of clots in the cerebral veins – known as sinus vein thrombosis, or CSVT
Introducing ‘Vaxzevria’: AstraZeneca renames Covid vaccine as firm fights off controversy over drug
AstraZeneca has renamed its Covid-19 vaccine, a move that coincides with the company’s struggle to reassure the public that its drug is safe, following numerous reports of potential adverse effects.